GENEVA, Dec. 3, 2025 /PRNewswire/ --Â EspeRare, a pioneering Geneva-based nonprofit biotech, announced today that it has been awarded a Grand Challenges grant from the Gates Foundation. This milestone strengthens EspeRare's mission to bring life-changing therapies to patients in under-resourced settings worldwide.
The Grand Challenges initiative, funded by the Gates Foundation, supports bold ideas that drive innovation to address pressing global health and development challenges. The grant will advance the development of a novel therapeutic approach for preeclampsia, a severe and potentially life-threatening pregnancy complication characterized by high blood pressure and organ dysfunction. Preeclampsia affects millions of women and babies every year and remains a leading cause of maternal and neonatal mortality, particularly in low-resource regions. Current treatment options are limited, with premature delivery often being the only option.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.